Jump to content
  • Our Mission Pooling competencies – pushing innovations

    BIOPRO Baden-Württemberg GmbH supports the medical technology, biotechnology and pharmaceutical sectors in the healthcare industry as well as the development of a bioeconomy in Baden-Württemberg.

  • Healthcare industry BW Industry report

    We track the economic performance of companies actively engaged in biotechnology, medical technology and pharmaceutical industry. Our publications provide the latest facts und figures for Baden-Württemberg’s healthcare industry.

  • Bioeconomy BW Towards greater sustainability

    We support regional bioeconomic strategies to promote and strengthen sustainability objectives in Baden-Württemberg. These strategies include regional research and development capacities, analyse approaches for circular economy and aim at the establishment of interfaces to both internal and external partners.

Latest news

The bioeconomy and the healthcare sector are seen as strategically important future sectors in the EU's Strategy for the Alpine Region. BIOPRO Baden-Württemberg GmbH is the lead partner in the EU-cofinanced ARDIA-Net project, which got underway in October 2019. The aim of the project is to develop a transnational funding programme for research, development and innovation (R&I) for regional and local authorities in the Alpine macroregion. Baden-Württemberg has a lot to offer for founders and start-ups. The entire diversity of Baden-Württemberg's start-up landscape will be on display at the Start-up BW Summit on July 23 and 24, 2020.


New on ...

... Healthcare industry BW

Yuri, a start-up company founded in 2019 in the Lake Constance area, is aiming high. The company’s mission is to enable microgravity research into the development of materials, new medicines and vaccines, including research opportunities on the International Space Station (ISS). Yuri’s tailor-made solutions are faster and more affordable than previous space research missions.

... Healthcare industry BW

The SARS-CoV-2 coronavirus uses a spike protein to bind to the ACE2 receptor on the cell surfaces of lung tissue. Additional cofactors are needed to allow the virus genome to penetrate human cells and multiply. Knowing these relationships can help understand the course of the infection and develop counterstrategies. To this end, the Constance-based company Trenzyme has produced a recombinant spike protein to support coronavirus research.

... Healthcare industry BW

The CRISPR-Cas gene-editing technology is one of the most important developments in molecular biology in recent years. It utilises molecular scissors with which nucleic acids can be cut and edited almost arbitrarily. Researchers in Freiburg, Germany have now successfully used the technology for diagnostic purposes. They are currently working intensively on expanding the system to enable it to detect genome sequences of the novel SARS-CoV-2 virus.

... Bioeconomy in BW

Innovative technologies and bacteria can transform wood residues into sustainable bioplastic packaging. Before bioplastics are broken down into CO2 and water in an environmentally friendly way, they can thus lead lives as products in the cosmetics industry, for example.

... Bioeconomy in BW

NovoCarbo GmbH produces biochar from plant residues such as wood chips, nutshells and manure. Different feedstocks, and the way these materials are processed, create biochars with different properties. This makes biochar suitable for different uses, including as a soil conditioner, in biogas plants or as bedding for stables and cowsheds. The Rhizo-Linse project is currently investigating whether biochar is also suitable as inoculant carrier for lentil plant growth-promoting bacteria.

... Bioeconomy in BW

Biomass from forestry and agriculture along with residues from industry and households can contribute to our energy and raw material shift. Sustainable, regenerative biomass-based energy can become part of the energy mix of the future within the framework of a bioeconomy.

Website address: https://www.bio-pro.de/en